The store will not work correctly when cookies are disabled.
3-[5-(3-Methoxy-phenyl)-1H-imidazol-2-yl]-pyridine
ID: ALA422608
PubChem CID: 44345802
Max Phase: Preclinical
Molecular Formula: C15H13N3O
Molecular Weight: 251.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(-c2c[nH]c(-c3cccnc3)n2)c1
Standard InChI: InChI=1S/C15H13N3O/c1-19-13-6-2-4-11(8-13)14-10-17-15(18-14)12-5-3-7-16-9-12/h2-10H,1H3,(H,17,18)
Standard InChI Key: WVEHTLXKAPWDJX-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
3.5917 -0.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0917 -0.2542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.1167 -1.5917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3125 -0.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3292 -1.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4125 -0.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6375 -0.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8917 -0.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6667 -1.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8417 -1.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2167 0.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5333 -0.3125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8042 -0.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7042 0.7583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0250 1.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0625 -0.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2792 0.8708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2083 0.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -0.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 3 1 0
6 1 1 0
7 4 1 0
8 7 2 0
9 10 2 0
10 6 1 0
11 8 1 0
12 11 1 0
13 6 2 0
14 7 1 0
15 14 2 0
16 19 2 0
17 15 1 0
18 12 1 0
19 13 1 0
5 4 2 0
16 9 1 0
17 11 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 251.29 | Molecular Weight (Monoisotopic): 251.1059 | AlogP: 3.15 | #Rotatable Bonds: 3 |
Polar Surface Area: 50.80 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.65 | CX Basic pKa: 5.10 | CX LogP: 2.54 | CX LogD: 2.54 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.78 | Np Likeness Score: -1.08 |
References
1. Elliott RL, Oliver RM, LaFlamme JA, Gillaspy ML, Hammond M, Hank RF, Maurer TS, Baker DL, DaSilva-Jardine PA, Stevenson RW, Mack CM, Cassella JV.. (2003) Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists., 13 (20): [PMID:14505677] [10.1016/s0960-894x(03)00747-9] |